From: Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
DFS | OS | |||||
---|---|---|---|---|---|---|
% events | Mean survival, years (SE) | p | % events | Mean survival, years (SE) | p | |
GCDFP-15 | 0.044 | |||||
Negative | 30.3 | 5.85 (0.24) | 19.3 | 7.07 (0.23) | ||
Positive | 25.1 | 6.67 (0.30) | 0.052 | 13.9 | 7.75 (0.27) | |
HR | 0.013 | |||||
Negative | 35.6 | 5.53 (0.36) | 23.3 | 6.75 (0.34) | ||
Positive | 25.0 | 6.48 (0.23) | 0.004 | 19.3 | 7.67 (0.34) | |
HER2 | 0.686 | |||||
Negative | 26.3 | 6.31 (0.22) | 16.0 | 7.46 (0.21) | ||
Positive | 37.0 | 5.64 (0.40) | 0.114 | 22.3 | 7.06 (0.24) | |
Biological tumor types | 0.084 | |||||
HR+/HER2- | 23.2 | 6.61 (0.25) | 13.7 | 7.71 (0.24) | ||
HR+/HER2+ | 33.8 | 5.86 (0.52) | 16.9 | 7.45 (0.43) | ||
HR-/HER2+ | 43.6 | 4.98 (0.60) | 30.8 | 6.23 (0.53) | ||
HR-/HER2- | 33.3 | 5.59 (0.42) | 0.011 | 21.1 | 6.86 (0.41) | |
Age | 0.046 | |||||
< 50 years | 24.9 | 6.48 (0.28) | 12.8 | 7.79 (0.25) | ||
> = 50 years | 31.0 | 5.93 (0.26) | 0.120 | 20.8 | 7.06 (0.24) | |
Histological type | 0.915 | |||||
Ductal/others | 28.8 | 6.15 (0.20) | 17.2 | 7.40 (0.19) | ||
Lobular | 10.0 | 6.42 (0.55) | 0.309 | 17.4 | 6.82 (0.55) | |
grading | 0.043 | |||||
G1-2 | 26.4 | 6.42 (0.22) | 16.1 | 7.54 (0.20) | ||
G3 | 34.6 | 5.35 (0.41) | 0.005 | 20.8 | 6.70 (0.40) | |
cT | 0.001 | |||||
cT1-2 | 20.8 | 6.90 (0.24) | 12.4 | 7.88 (0.22) | ||
cT3-4 | 43.9 | 4.93 (0.31) | <0.0001 | 26.7 | 6.65 (0.31) | |
cN | <0.0001 | |||||
cN0 | 22.4 | 6.91 (0.28) | 11.4 | 8.12 (0.24) | ||
cN+ | 33.9 | 5.56 (0.26) | <0.0001 | 22.5 | 6.75 (0.25) |